Tsukasaki Kunihiro | Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
スポンサーリンク
概要
- 同名の論文著者
- Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseasesの論文著者
関連著者
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
東海大学 医学部
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Seto M
Department Of Hematology And Chemotherapy
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
三木 義男
癌研ゲノムセンター
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Yamada Y
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Yamada Yasuaki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Yamada Y
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Yamada Yasuaki
Department Of Laboratory Medicine Nagasaki University Graduate School Of Biomedical Sciences
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
谷脇 雅文
高知工科大学工学部
-
Yamada Yasuaki
富山大学 工学部
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TAKASAKI Yumi
Nagasaki CML Study Group
-
Kohno S
Second Dep. Of Internal Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ
-
Onishi Yasushi
Department Of Biostatistics School Of Public Health University Of Tokyo
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
Kamihira Shimeru
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Sugahara Kazuyuki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Kawakami S
Santen Pharmaceutical Co. Ltd. Nara Research And Development Center:department Of Hospital Pharmacy
-
Kawakami Shigeru
京都大学 薬学研究科
-
Kohno Shigeru
長崎大学医学部歯学部附属病院 薬剤部
-
YAMADA Yasuaki
Department of Laboratory Medicine, Nagasaki University School of Medicine
-
Kawakami S
Department Of Laboratory Medicine Nagasaki University Graduate School Of Biomedical Sciences
-
Sugahara Yazuyuki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
上平 憲
長崎大学医学部附属病院検査部
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
Kohno Shigeru
佐世保市立総合病院
-
Hirakata Yoichi
長崎大学 医学部第二内科学
-
上平 憲
長崎大学臨床検査医学
-
Sugahara Kazuyuki
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
KAMIHIRA Shimeru
Department of Laboratory Medicine, Nagasaki University School of Medicine
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
FUKUSHIMA Takuya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OHNO Ryuzo
Aichi Cancer Center
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
UEDA Takanori
First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui
-
Kohno Shigeru
長崎大学 医学部第二内科
-
Yamanaka Kiyoharu
北里大学 医学部微生物・寄生虫学
-
Yanagihara Katsunori
長崎大学 医学部第二内科
-
Yanagihara Katsunori
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Yanagihara Katsunori
Second Dep. Of Internal Medicine Nagasaki Univ. School Of Medicine
-
Yoshida S
Chiba University
-
Miyazaki Y
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
MIYAGI MAESHIMA
Clinical Laboratory, National Cancer Center Hospital
-
KIM Sung-Won
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
上平 憲
長崎大学大学院 臨床検査医学
-
Kawakami Shigeru
Dep. Of Drug Delivery Res. Graduate School Of Pharmaceutical Sciences Kyoto Univ.
-
Ohashi Yasuo
Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences a
-
Yamada Osamu
Division of Pediatrics, National Cardiovascular Center
-
Kohno Shigeru
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Kohno Shigeru
Nagasaki University
-
Doi Yuko
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Yamaguchi Toshiyuki
Department Of Laboratory Medicine
-
TANAKA Yuetsu
Department of Immunology, School of Hygienic Sciences, Kitasato University
-
YAMAGUCHI Tosiyuki
the Department of Laboratory Midicine
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
TERAUCHI Takashi
Screening Technology and Development Division, Research Center for Cancer Prevention and Screening,
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
Ogawa Daisuke
Nagasaki Cml Study Group
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
SAKAI Mari
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MATSUO Emi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIUCHI Yukiyoshi
Nagasaki CML Study Group
-
IMAIZUMI Yoshitaka
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUSHIMA Hideki
Nagasaki CML Study Group
-
INOUE Yoriko
Nagasaki CML Study Group
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
河野 茂
長崎大学 医学部 第二内科
-
河野 茂
長崎大学医学部附属病院 光学医療診療部
-
Kawabata S
Second Dep. Of Internal Medicine Nagasaki Univ. School Of Medicine
-
河野 茂
長崎大学大学院医歯薬学総合研究科
-
Suzuki Tatsuya
Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University
-
SUZUKI Yoshihiko
Suzuki clinic
-
Kato Harumi
Department of Cardiology, Kurashiki Central Hospital
-
Tsukamoto Norifumi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
TAKAUE Yoichi
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Morinaga Yoshitomo
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Morinaga Yoshitomo
Izumikawa Hospital
-
Yanagihara Katsunori
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Izumikawa Koichi
長崎大学 医学部第二内科
-
Izumikawa Koichi
北九州市立八幡病院
-
TANIGUCHI Hirokazu
Clinical Laboratory, National Cancer Center Hospital
-
NOMOTO Junko
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
YAMASAKI Satoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TSUCHIYA Takahide
Department of Hematology and Oncology, Tokai University School of Medicine
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Maeda Yasuhiro
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Maeda Yasuhiro
近畿大学 第3内科
-
OGAWA Daisuke
Department of Medicine and Clinical Science (Internal Medicine III), Okayama University Graduate Sch
-
Koji Takehiko
Department Of Histology And Cell Biology Nagasaki University Graduate School Of Biomedical Sciences
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
Kohno Shigeru
佐世保市立総合病院 内科
-
河野 茂
長崎大学大学院医歯薬学総合研究科感染分子病態学講座
-
Takagi K
Department Of Medical Technology Nagoya University School Of Health Sciences
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
SHIMOKAWA Isao
Department of Pathology, National Hospital Organization Saga Hospital
-
OHNO Toshihito
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
DOI Yuko
Department of Pathology, Akita University School of Medicine
-
MURATA Ken
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
FUJITA Masatoshi
Laboratory of Viral Oncology, Research Institute, Aichi Cancer Center
-
HIGAMI Yoshikazu
Department of Pathology, Nagasaki University School of Medicine
-
MAEDA Michiyuki
Chest Disease Institute, Kyoto University
-
FURUKAWA Koichi
Department of Oncology, Nagasaki University School of Medicine
-
YOSHIKI Takashi
Department of Pathology, Hokkaido University School of Medicine
-
SHIKU Hiroshi
Second Department of Internal Medicine, Mie University School of Medicine
-
KAMIHIRA Shimeru
the Department of Laboratory Midicine
-
YAMADA Yasuaki
the Department of Laboratory Midicine
-
HIRAGATA Youichi
the Department of Laboratory Midicine
-
IZUMIKAWA Kohichi
the Department of Laboratory Midicine
-
SUGAHARA Kazuyuki
the Department of Laboratory Midicine
-
ATOGAMI Sunao
the Department of Haematology of Atomic Disease Institute, Nagasaki University School of Medicine
-
TSUKASAKI Kunihiro
the Department of Haematology of Atomic Disease Institute, Nagasaki University School of Medicine
-
MAEDA Takahiro
the Department of Haematology of Atomic Disease Institute, Nagasaki University School of Medicine
-
TOMONAGA Masao
the Department of Haematology of Atomic Disease Institute, Nagasaki University School of Medicine
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Hishikawa Yoshitaka
Department of Histology and Cell Biology, Unit of Basic Medical Science, Nagasaki University Graduat
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
ENDO Keigo
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicin
-
SETO Masao
Laboratories of Chemotherapy and Immunology, Aichi Cancer Research Institute
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
ASAI Osamu
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUCHIYA Takeshi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOMODA Minori
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
著作論文
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Clinical differences between hypoplastic and normocellular or hyperplastic myelodysplastic syndrome
- Comparative effects of three nitrosourea derivatives on cell cycle kinetics
- Flow Microfluorometric Analysis of Cell Kinetics with Antileukemic Drugs
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Change of serum erythropoietin levels after allogeneic bone marrow transplantation
- Changes in M-CSF activity and CFU-GM- Inhibitory activity in the urine of patient with cyclic chronic myelogenous leukemia
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95